Transdermal nitroglycerin therapy may not prevent early postmenopausal bone loss

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 9, 2009, Pages 3356-3364

  Wimalawansa, Sunil J ^a   Grimes, Julia P ^a   Wilson, Alan C ^a   Hoover, Donald R ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITRATE CALCIUM; GLYCERYL TRINITRATE; PLACEBO; VITAMIN D;

ADULT; AGED; ARTICLE; BONE DENSITY; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DUAL ENERGY X RAY ABSORPTIOMETRY; EVENING DOSAGE; FEMALE; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; LABORATORY TEST; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; MIGRAINE; MUSCULOSKELETAL DISEASE; NEOPLASM; OINTMENT; OSTEOLYSIS; PATIENT COMPLIANCE; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION;

ANIMALIA;

EID: 69949086107     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2225     Document Type: Article

References (42)

1. Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs Jr RW, Dequeker J, Favus M 1995 Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 333:1437-1443
2. Horsman A, Jones M, Francis R, Nordin C 1983 The effect of estrogen dose on postmenopausal bone loss. N Engl J Med 309:1405-1407 (Pubitemid 14245135)
3. Wimalawansa S, Chapa T, Fang L, Yallampalli C, Simmons D, Wimalawansa S 2000 Frequency-dependent effect of nitric oxide donor nitroglycerin on bone. J Bone Miner Res 15:1119-1125 (Pubitemid 30350074)
4. Armour KE, Ralston SH 1998 Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells. Endocrinology 139:799-802 (Pubitemid 28513235)
5. Aguirre J, Buttery L, O'Shaughnessy M, Afzal F, Fernandez de Marticorena I, Hukkanen M, Huang P, MacIntyre I, Polak J 2001 Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity. Am J Pathol 158:247-257 (Pubitemid 32096490)
6. Armour KE, Armour KJ, Gallagher ME, Godecke A, Helfrich MH, Reid DM, Ralston SH 2001 Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase. Endocrinology 142:760-766 (Pubitemid 32222425)
7. Wimalawansa SJ 2000 Nitroglycerin therapy is as efficacious as standard estrogen replacement therapy (Premarin) in prevention of oophorectomy-induced bone loss: a human pilot clinical study. J Bone Miner Res 15:2240-2244
8. Wimalawansa SJ, De Marco G, Gangula P, Yallampalli C 1996 Nitric oxide donor alleviates ovariectomy-induced bone loss. Bone 18:301-304 (Pubitemid 26149339)
9. Romagnoli E, Minisola S, Carnevale V, Scarda A, Rosso R, Scarnecchia L, Pacitti MT, Mazzuoli G 1993 Effect of estrogen deficiency on IGF-I plasma levels: relationship with bone mineral density in perimenopausal women. Calcif Tissue Int 53:1-6 (Pubitemid 23187323)
10. Johansson AG, Eriksen EF, Lindh E, Langdahl B, Blum WF, Lindahl A, Ljunggren O, Ljunghall S 1997 Reduced serum levels of the growth hormone-dependent insulin-like growth factor binding protein and a negative bone balance at the level of individual remodeling units in idiopathic osteoporosis in men. J Clin Endocrinol Metab 82:2795-2798 (Pubitemid 27385626)
11. Hill PA, Reynolds JJ, Meikle MC 1995 Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function. Endocrinology 136:124-131
12. Wimalawansa SJ, Chapa MT, Yallampalli C, Zhang R, Simmons DJ 1997 Prevention of corticosteroid-induced bone loss with nitric oxide donor nitroglycerin in male rats. Bone 21:275-280 (Pubitemid 27404085)
13. MacIntyre I, Zaidi M, Alam AS, Datta HK, Moonga BS, Lidbury PS, Hecker M, Vane JR 1991 Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP. Proc Natl Acad Sci USA 88:2936-2940 (Pubitemid 21916535)
14. Ralston SH, Ho LP, Helfrich MH, Grabowski PS, Johnston PW, Benjamin N 1995 Nitric oxide: a cytokine-induced regulator of bone resorption. J Bone Miner Res 10:1040-1049
15. Ralston SH, Todd D, Helfrich M, Benjamin N, Grabowski PS 1994 Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 135:330-336 (Pubitemid 24203834)
16. Hukkanen M, Hughes FJ, Buttery LD, Gross SS, Evans TJ, Seddon S, Riveros-Moreno V, Macintyre I, Polak JM 1995 Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity. Endocrinology 136:5445-5453
17. Riancho JA, Zarrabeitia MT, Fernandez-Luna JL, Gonzalez-Macias J 1995 Mechanisms controlling nitric oxide synthesis in osteoblasts. Mol Cell Endocrinol 107:87-92
18. Tsukahara H, Miura M, Tsuchida S, Hata I, Hata K, Yamamoto K, Ishii Y, Muramatsu I, Sudo M 1996 Effect of nitric oxide synthase inhibitors on bone metabolism in growing rats. Am J Physiol 270:E840-E845 (Pubitemid 26181969)
19. Brandi ML, Hukkanen M, Umeda T, Moradi-Bidhendi N, Bianchi S, Gross SS, Polak JM, MacIntyre I 1995 Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms. Proc Natl Acad Sci USA 92:2954-2958
20. Chae HJ, Park RK, Chung HT, Kang JS, Kim MS, Choi DY, Bang BG, Kim HR 1997 Nitric oxide is a regulator of bone remodelling. J Pharm Pharmacol 49:897-902
21. Kasten TP, Collin-Osdoby P, Patel N, Osdoby P, Krukowski M, Misko TP, Settle SL, Currie MG, Nickols GA 1994 Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase. Proc Natl Acad Sci USA 91:3569-3573 (Pubitemid 24139471)
22. Wimalawansa SJ 2000 Restoration of ovariectomy-induced osteopenia by nitroglycerin. Calcif Tissue Int 66:56-60
23. Riancho JA, Salas E, Zarrabeitia MT, Olmos JM, Amado JA, Fernandez-Luna JL, Gonzalez-Macias J 1995 Expression and functional role of nitric oxide synthase in osteoblast-like cells. J Bone Miner Res 10:439-446
24. Wimalawansa SJ 2008 Nitric oxide: novel therapy for osteoporosis Expert Opin Pharmacother 9:1-19
25. Wimalawansa SJ 2007 Rationale for using nitric oxide donor therapy for prevention of bone loss and treatment of osteoporosis in humans. Ann NY Acad Sci 1117:283-297
26. Wimalawansa SJ 2008 Nitric oxide: new evidence for novel therapeutic indications. Expert Opin Pharmacother 9:1935-1954
27. Griffith P, James B, Cropp A 1994 Evaluation of the safety and efficacy of topical nitroglycerin ointment to facilitate venous cannulation. Nurs Res 43:203-206
28. Riegel B, Heywood G, Jackson W, Kennedy A 1988 Effect of nitroglycerin ointment placement on the severity of headache and flushing in patients with cardiac disease. Heart Lung 17:426-431 (Pubitemid 18186277)
29. Wimalawansa SJ 1998 Four-year randomized prospective study: an efficacious therapy for established postmenopausal osteoporosis with the combination of estrogen and bisphosphonate. Am J Med 104:219-226
30. Nabhan AF, Rabie NH 2008 Isosorbide mononitrate versus alendronate for postmenopausal osteoporosis. Int J Gynaecol Obstet 103:213-216
31. Pitsillides AA, Rawlinson SC, Suswillo RF, Bourrin S, Zaman G, Lanyon LE 1995 Mechanical strain-induced NO production by bone cells: a possible role in adaptive bone (re)modeling? FASEB J 9:1614-1622 (Pubitemid 26012849)
32. Turner CH, Takano Y, Owan I, Murrell GA 1996 Nitric oxide inhibitor L-NAME suppresses mechanically induced bone formation in rats. Am J Physiol 270:E634-E639 (Pubitemid 126756535)
33. Klein-Nulend J, Semeins CM, Ajubi NE, Nijweide PJ, Burger EH 1995 Pulsating fluid flow increases nitric oxide (NO) synthesis by osteocytes but not periosteal fibroblasts-correlation with prostaglandin upregulation. Biochem Biophys Res Commun 217:640-648 (Pubitemid 26011757)
34. Zaman G, Pitsillides AA, Rawlinson SC, Suswillo RF, Mosley JR, Cheng MZ, Platts LA, Hukkanen M, Polak JM, Lanyon LE 1999 Mechanical strain stimulates nitric oxide production by rapid activation of endothelial nitric oxide synthase in osteocytes. J Bone Miner Res 14:1123-1131 (Pubitemid 29314055)
35. Corbett SA, Hukkanen M, Batten J, McCarthy ID, Polak JM, Hughes SP 1999 Nitric oxide in fracture repair. Differential localisation, expression and activity of nitric oxide synthases. J Bone Joint Surg Br 81:531-537 (Pubitemid 29245914)
36. Corbett SA, McCarthy ID, Batten J, Hukkanen M, Polak JM, Hughes SP 1999 Nitric oxide mediated vasoreactivity during fracture repair. Clin Orthop Relat Res 247-253 (Pubitemid 29382282)
37. Diwan AD, Wang MX, Jang D, Zhu W, Murrell GA 2000 Nitric oxide modulates fracture healing. J Bone Miner Res 15:342-351 (Pubitemid 30095722)
38. Wimalawansa SJ 2008 Skeletal effects of nitric oxide: a novel agent for osteoporosis. In: Bilizikian J, Laize R, Martin TJ, eds. Bone biology. New York: Blackwell Scientific; 1275-1311
39. Rejnmark L, Vestergaard P, Mosekilde L 2006 Decreased fracture risk in users of organic nitrates: a nationwide case-control study. J Bone Miner Res 21:1811-1817 (Pubitemid 46141238)
40. Jamal SA, Goltzman D, Hanley DA, Papaioannou A, Prior JC, Josse RG 2009 Nitrate use and changes in bone mineral density: the Canadian Multicentre Osteoporosis Study. Osteoporos Int 20:737-744
41. Jamal SA, Cummings SR, Hawker GA 2004 Isosorbide mononitrate increases bone formation and decreases bone resorption in postmenopausal women: a randomized trial. J Bone Miner Res 19:1512-1517
42. Kala R, Hirvonen P, Gordin A, Sundberg S, Auvinen J, Halonen PI 1983 Nitroglycerin ointment effective for seven hours in severe angina pectoris. Acta Med Scand 213:165-170 (Pubitemid 13130085)